PhD Candidate Tara Helen Dowling

BS in biology and MS in biomedicine, both from the University of Bergen. She has since 2016 been a PhD candidate in the McCormack and Gjertsen groups. Her PhD project focuses on developing novel hBMSC derived scaffold mouse models and identifying potential treatable biomarkers, with an aim to aid the development of new therapeutic modalities for myeloid leukemias.